SOX10 and glioblastoma: Furthermore, analogous to the Sox10-KD conditions, a distinct, though statistically not significant, sensitization to Fimepinostat antiproliferative treatment was observed in TMZ-treated human glioblastoma control cells (Fig. EV4D).